O'Dell Group’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-60
Closed -$58 154
2023
Q4
$58 Buy
+60
New +$59 ﹤0.01% 499
2023
Q3
Sell
-60
Closed -$54 140
2023
Q2
$54 Buy
+60
New +$53 ﹤0.01% 509
2022
Q4
Sell
-60
Closed 130
2022
Q3
$0 Hold
60
﹤0.01% 424
2022
Q2
$0 Hold
60
﹤0.01% 475
2022
Q1
$0 Buy
+60
New +$174 ﹤0.01% 521

Other funds holding CLOV

O'Dell Group's CLOV Position: Q1 2024 in Review

O'Dell Group sold out of Clover Health Investments (CLOV) in Q1 2024, closing a stake of 60 shares — an estimated $58 sold.

O'Dell Group first reported a position in CLOV in Q1 2022 and held it in 5 quarters. The position peaked at $58 in Q4 2023. 137 funds tracked by Wall St. Rank hold CLOV as of Q1 2024.

  • O'Dell Group reported no remaining Clover Health Investments position as of Q1 2024 after selling out during the quarter.
  • O'Dell Group sold 60 Clover Health Investments shares in Q1 2024, an estimated $58.
  • O'Dell Group first reported a position in Clover Health Investments in Q1 2022 and held it in 5 quarters.
  • O'Dell Group's Clover Health Investments position peaked at $58 in Q4 2023.
  • 137 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2024.

Based on O'Dell Group's 13F filing for Q1 2024, filed 7 May 2024.